Regulation of apoptosis in squamous cell carcinoma of the vulva

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 45, Issue 8, 2000, Pages 633-642

  Hantschmann, P ^a   Kurzl, R ^a  

^a NONE   (Germany)

Author keywords

Apoptosis; Bcl 2 genes; Vulvar neoplasms

Indexed keywords

CASPASE 9; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; CONFERENCE PAPER; CORRELATION FUNCTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL; VULVA CARCINOMA;

EID: 0033838233     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Individualized treatment of stage 1 carcinoma of the vulva
2. Stage I squamous cell cancer of the vulva
3. Operative management of early invasive epidermoid carcinoma of the vulva
4. Infiltrative carcinoma of the vulva: Results of surgical treatment
5. Prognostic factors in epidermoid carcinoma of the vulva
6. Squamous cell carcinoma of the vulva: Prognostic factors influencing survival
7. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)
8. Cell death: The significance of apoptosis
9. Cloning and structural analysis of cDNAs for Bcl-2 and a hybrid Bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
10. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
11. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
12. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
13. Induction of apoptosis by the Bcl-2 homologue Bak
14. Cloning of a Bcl-2 homologue by interaction with adenovirus E1B 19K
15. Importance of the Bcl-2 family in cell death regulation
16. Involvement of an ICE-like protease in Fas-mediated apoptosis
17. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
18. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
19. Measurement of apoptosis
20. Measurement of cell death
21. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients
22. MIB-1 expression in breast carcinomas with medullary features: An immunohistological study including correlations with p53 and Bcl-2
23. Expression of the apoptosis suppressing protein Bcl-2 in prostatic adenocarcinoma is related to tumor malignancy
24. The expression of waf-1,p53 and Bcl-2 in prostatic adenocarcinoma
25. Apoptosis Bcl-2 and p53 expression and their relation to tumour stage in non-small cell lung carcinomas (NSCLC)
26. Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: Immunohistochemical and clinicopathological study
27. Histologic malignancy grading in invasive squamous cell carcinoma of the vulva
28. Ki-67 expression in vulvar carcinoma
29. Immunhistologischer Nachweis von MIB-1 in Plattenepithelkarzinomen der Vulva: Farbeverhalten und Korrelation zu Prognosefaktoren
30. S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancer
31. p53 Protein expression in squamous cell carcinoma of the vulva
32. Expression of tumor proteases Cathepsin-D and pro-Cathepsin-L in squamous cell carcinoma of the vulva
33. PCNA, Ki-67, p53, Bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck
34. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and Bcl-2 protein products
35. Bcl-2 Expression in endometrial hyperplasia and carcinoma
36. Expression of Bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis
37. Bcl-2: Role in epithelial differentiation and oncogenesis
38. Expression of Bcl-2 oncoprotein in gastrointestinal and Uterine carcinomas and their premalignant lesions
39. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions
40. Differential expression of apoptosis associated genes bax and Bcl-2 in ovarian cancer
41. Prognostic value of the expression of p53, Bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
42. The role of p53, p21WAF1/C1PI, and Bcl-2 in radioresistant colorectal carcinoma
43. PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris
44. Prognostic role of histology in squamous cell carcinoma in the vulvar region
45. Prognostic factors in carcinoma of the vulva
46. Expression of Bfl-1 in normal and tumor tissues: Bfl-1 overexpression in cancer is attributable to its preferential expression in infiltrating inflammatory cells
47. Expression of Bcl-2 in lichen planus acute graft-versus-host disease, and erythema multiforme
48. Expression of Bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis
49. Cytotoxic mechanisms in inflammatory myopathies: Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells
50. Analysis of Bcl-2+ lymphocyte subpopulations in inflammatory synovial infiltrates by a double-immunostaining technique